These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 11487732)

  • 21. Predictors for hemorrhagic transformation with intravenous tissue plasminogen activator in acute ischemic stroke.
    Moriya Y; Takahashi W; Kijima C; Yutani S; Iijima E; Mizuma A; Honma K; Uesugi T; Ohnuki Y; Nagata E; Yanagimachi N; Takizawa S
    Tokai J Exp Clin Med; 2013 Apr; 38(1):24-7. PubMed ID: 23564572
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Magnetic resonance prediction of outcome after thrombolytic treatment.
    Pillekamp F; Grüne M; Brinker G; Franke C; Uhlenküken U; Hoehn M; Hossmann K
    Magn Reson Imaging; 2001 Feb; 19(2):143-52. PubMed ID: 11358651
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Reduction of tissue plasminogen activator-induced hemorrhage and brain injury by free radical spin trapping after embolic focal cerebral ischemia in rats.
    Asahi M; Asahi K; Wang X; Lo EH
    J Cereb Blood Flow Metab; 2000 Mar; 20(3):452-7. PubMed ID: 10724108
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of a selective CD11b/CD18 antagonist and recombinant human tissue plasminogen activator treatment alone and in combination in a rat embolic model of stroke.
    Zhang L; Zhang ZG; Zhang RL; Lu M; Krams M; Chopp M
    Stroke; 2003 Jul; 34(7):1790-5. PubMed ID: 12805500
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Differences in clot preparation determine outcome of recombinant tissue plasminogen activator treatment in experimental thromboembolic stroke.
    Niessen F; Hilger T; Hoehn M; Hossmann KA
    Stroke; 2003 Aug; 34(8):2019-24. PubMed ID: 12843350
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Application of albumin prior to delayed thrombolysis reduces brain edema and blood brain barrier permeability in an embolic stroke model.
    Lu HT; Zhao JG; Li MH; Li YD
    Brain Res; 2012 Feb; 1438():75-84. PubMed ID: 22227456
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Glycoprotein IIb/IIIa antagonist, murine 7E3 F(ab') 2, and tissue plasminogen activator in focal ischemia: evaluation of efficacy and risk of hemorrhage with combination therapy.
    Shuaib A; Yang Y; Nakada MT; Li Q; Yang T
    J Cereb Blood Flow Metab; 2002 Feb; 22(2):215-22. PubMed ID: 11823719
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Multitargeted effects of statin-enhanced thrombolytic therapy for stroke with recombinant human tissue-type plasminogen activator in the rat.
    Zhang L; Zhang ZG; Ding GL; Jiang Q; Liu X; Meng H; Hozeska A; Zhang C; Li L; Morris D; Zhang RL; Lu M; Chopp M
    Circulation; 2005 Nov; 112(22):3486-94. PubMed ID: 16316970
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Early prediction of gross hemorrhagic transformation by noncontrast agent MRI cluster analysis after embolic stroke in rat.
    Ding G; Nagesh V; Jiang Q; Zhang L; Zhang ZG; Li L; Knight RA; Li Q; Ewing JR; Chopp M
    Stroke; 2005 Jun; 36(6):1247-52. PubMed ID: 15879323
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prediction of hemorrhagic transformation after experimental ischemic stroke using MRI-based algorithms.
    Bouts MJ; Tiebosch IA; Rudrapatna US; van der Toorn A; Wu O; Dijkhuizen RM
    J Cereb Blood Flow Metab; 2017 Aug; 37(8):3065-3076. PubMed ID: 28155583
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Probability of metabolic tissue recovery after thrombolytic treatment of experimental stroke: a magnetic resonance spectroscopic imaging study in rat brain.
    Franke C; Brinker G; Pillekamp F; Hoehn M
    J Cereb Blood Flow Metab; 2000 Mar; 20(3):583-91. PubMed ID: 10724122
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Brain hemorrhages after rt-PA treatment of embolic stroke in spontaneously hypertensive rats.
    Brinker G; Pillekamp F; Hossmann KA
    Neuroreport; 1999 Jun; 10(9):1943-6. PubMed ID: 10501537
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Recombinant tissue-type plasminogen activator transiently enhances blood-brain barrier permeability during cerebral ischemia through vascular endothelial growth factor-mediated endothelial endocytosis in mice.
    Suzuki Y; Nagai N; Yamakawa K; Muranaka Y; Hokamura K; Umemura K
    J Cereb Blood Flow Metab; 2015 Dec; 35(12):2021-31. PubMed ID: 26219596
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Recombinant human tissue plasminogen activator protects the basal lamina in experimental focal cerebral ischemia.
    Burggraf D; Martens HK; Jäger G; Hamann GF
    Thromb Haemost; 2003 Jun; 89(6):1072-80. PubMed ID: 12783121
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Relationship between magnetic resonance angiography-diffusion-weighted imaging mismatch and clinical outcome in endovascular treatment for acute ischemic stroke: subgroup analysis of the Recovery by Endovascular Salvage for Cerebral Ultra-acute Embolism--Japan Registry.
    Deguchi I; Dembo T; Yoshimura S; Sakai N; Okada Y; Kitagawa K; Kimura K; Hyogo T; Yamagami H; Egashira Y; Tanahashi N
    J Stroke Cerebrovasc Dis; 2014 Jul; 23(6):1471-6. PubMed ID: 24685994
    [TBL] [Abstract][Full Text] [Related]  

  • 36. MRI evaluation of treatment of embolic stroke in rat with intra-arterial and intravenous rt-PA.
    Jiang Q; Zhang ZG; Zhang L; Ding GL; Li L; Ewing JR; Lu M; Whitton P; Hu J; Li QJ; Zhang RL; Chopp M
    J Neurol Sci; 2004 Sep; 224(1-2):57-67. PubMed ID: 15450772
    [TBL] [Abstract][Full Text] [Related]  

  • 37. MRI-based ultrafast protocol thrombolysis with rt-PA for acute ischemia stroke in 12-hour time window.
    Li YH; Li MH; Zhao JG; Wang W
    J Neuroimaging; 2011 Oct; 21(4):332-9. PubMed ID: 21121996
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hematoma expansion in experimental intracerebral hemorrhage is not altered by peracute treatment with recombinant tissue plasminogen activator.
    Pfeilschifter W; Kashefiolasl S; Lauer A; Steinmetz H; Foerch C
    Neuroscience; 2013 Oct; 250():181-8. PubMed ID: 23856067
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antiactin-targeted immunoliposomes ameliorate tissue plasminogen activator-induced hemorrhage after focal embolic stroke.
    Asahi M; Rammohan R; Sumii T; Wang X; Pauw RJ; Weissig V; Torchilin VP; Lo EH
    J Cereb Blood Flow Metab; 2003 Aug; 23(8):895-9. PubMed ID: 12902833
    [TBL] [Abstract][Full Text] [Related]  

  • 40. LOX-1 and MMP-9 Inhibition Attenuates the Detrimental Effects of Delayed rt-PA Therapy and Improves Outcomes After Acute Ischemic Stroke.
    Arkelius K; Wendt TS; Andersson H; Arnou A; Gottschalk M; Gonzales RJ; Ansar S
    Circ Res; 2024 Apr; 134(8):954-969. PubMed ID: 38501247
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.